Paul A. Bird

St George & Sutherland Clinical School
Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

2024 Update of the Asia-Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management.

2024 Update of the Asia-Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management.

Journal: International journal of rheumatic diseases

Published: March 02, 2026

Structural damage assessment in the spine of patients with axial spondyloarthritis - results from an international OMERACT multi-reader exercise using MRI-based synthetic CT.

Structural damage assessment in the spine of patients with axial spondyloarthritis - results from an international OMERACT multi-reader exercise using MRI-based synthetic CT.

Journal: Seminars in arthritis and rheumatism

Published: November 19, 2025

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study.

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 10, 2025

The APLAR Recommendations for the Management of Psoriatic Arthritis.

The APLAR Recommendations for the Management of Psoriatic Arthritis.

Journal: International journal of rheumatic diseases

Published: February 27, 2025

A review and recommendations on the management of psoriatic arthritis in Australia 2024.

A review and recommendations on the management of psoriatic arthritis in Australia 2024.

Journal: Internal medicine journal

Published: January 22, 2024

Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset.

Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset.

Journal: Clinical and experimental rheumatology

Published: November 06, 2023

Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.

Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.

Journal: Clinical rheumatology

Published: October 31, 2023

Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings.

Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings.

Journal: Internal medicine journal

Published: October 03, 2023

The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee region.

The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee region.

Journal: Seminars in arthritis and rheumatism

Published: September 01, 2023

Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis.

Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis.

Journal: Seminars in arthritis and rheumatism

Published: September 01, 2023

Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia.

Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia.

Journal: JAMA network open

Published: June 29, 2023

Magnetic resonance imaging RAMRIS-SAFE score-A low-risk effective measure of rapid response to therapy in rheumatoid arthritis clinical trials.

Magnetic resonance imaging RAMRIS-SAFE score-A low-risk effective measure of rapid response to therapy in rheumatoid arthritis clinical trials.

Journal: International journal of rheumatic diseases

Published: May 03, 2023

Showing 1-12 of 85

Last Updated: 09/26/2026